{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:33:49Z","timestamp":1774571629009,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1245\/s10434-024-16455-7","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T18:04:49Z","timestamp":1731002689000},"page":"1011-1020","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Improving Recurrence Prediction in Intrahepatic Cholangiocarcinoma: The Synergistic Impact of the FIB-4 Index and Tumor Burden Score on Post-hepatectomy Outcomes"],"prefix":"10.1245","volume":"32","author":[{"given":"Miho","family":"Akabane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selamawit","family":"Woldesenbet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda B.","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Cauchy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shishir K.","family":"Maithel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bas","family":"Groot Koerkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin","family":"Alexandrescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Kitago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Martel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Pulitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Aldrighetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Poultsides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Imaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gleisner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo P.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7994-9870","authenticated-orcid":false,"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"16455_CR1","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268\u201389.","journal-title":"J Hepatol."},{"key":"16455_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","volume":"248","author":"I Endo","year":"2008","unstructured":"Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248:84\u201396.","journal-title":"Ann Surg."},{"key":"16455_CR3","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s00268-019-04966-4","volume":"43","author":"L Wu","year":"2019","unstructured":"Wu L, Tsilimigras DI, Paredes AZ, et al. Trends in the incidence, treatment, and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival. World J Surg. 2019;43:1777\u201387.","journal-title":"World J Surg."},{"key":"16455_CR4","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1245\/s10434-021-09671-y","volume":"28","author":"ZV Fong","year":"2021","unstructured":"Fong ZV, Brownlee SA, Qadan M, Tanabe KK. The clinical management of cholangiocarcinoma in the United States and Europe: a comprehensive and evidence-based comparison of guidelines. Ann Surg Oncol. 2021;28:2660\u201374.","journal-title":"Ann Surg Oncol."},{"key":"16455_CR5","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1002\/cncr.28312","volume":"119","author":"SK Maithel","year":"2013","unstructured":"Maithel SK, Gamblin TC, Kamel I, Corona-Villalobos CP, Thomas M, Pawlik TM. Multidisciplinary approaches to intrahepatic cholangiocarcinoma. Cancer. 2013;119:3929\u201342.","journal-title":"Cancer."},{"key":"16455_CR6","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1245\/s10434-014-3828-x","volume":"21","author":"AX Zhu","year":"2014","unstructured":"Zhu AX, Borger DR, Kim Y, et al. Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets. Ann Surg Oncol. 2014;21:3827\u201334.","journal-title":"Ann Surg Oncol."},{"key":"16455_CR7","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1007\/s11605-017-3550-7","volume":"21","author":"F Bagante","year":"2017","unstructured":"Bagante F, Spolverato G, Weiss M, et al. Defining long-term survivors following resection of intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2017;21:1888\u201397.","journal-title":"J Gastrointest Surg."},{"key":"16455_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","volume":"149","author":"MN Mavros","year":"2014","unstructured":"Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg. 2014;149:565\u201374.","journal-title":"JAMA Surg."},{"key":"16455_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1001\/jamasurg.2020.1973","volume":"155","author":"DI Tsilimigras","year":"2020","unstructured":"Tsilimigras DI, Sahara K, Wu L, et al. Very early recurrence after liver resection for intrahepatic cholangiocarcinoma: considering alternative treatment approaches. JAMA Surg. 2020;155:823\u201331.","journal-title":"JAMA Surg."},{"key":"16455_CR10","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43:1317\u201325.","journal-title":"Hepatology."},{"key":"16455_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1245\/s10434-016-5377-y","volume":"23","author":"Y Okamura","year":"2016","unstructured":"Okamura Y, Ashida R, Yamamoto Y, Ito T, Sugiura T, Uesaka K. FIB-4 index is a predictor of background liver fibrosis and long-term outcomes after curative resection of hepatocellular carcinoma. Ann Surg Oncol. 2016;23:467\u201374.","journal-title":"Ann Surg Oncol."},{"key":"16455_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hep.22576","volume":"49","author":"S Naveau","year":"2009","unstructured":"Naveau S, Gaud\u00e9 G, Asnacios A, et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology. 2009;49:97\u2013105.","journal-title":"Hepatology."},{"key":"16455_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"SI Ilyas","year":"2018","unstructured":"Ilyas SI, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma: evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15:95\u2013111.","journal-title":"Nat Rev Clin Oncol."},{"key":"16455_CR14","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383:2168\u201379.","journal-title":"Lancet."},{"key":"16455_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5391-0","volume":"19","author":"PL Labib","year":"2019","unstructured":"Labib PL, Goodchild G, Pereira SP. Molecular pathogenesis of cholangiocarcinoma. BMC Cancer. 2019;19:1\u201316.","journal-title":"BMC Cancer."},{"key":"16455_CR16","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1245\/s10434-020-09393-7","volume":"28","author":"DI Tsilimigras","year":"2021","unstructured":"Tsilimigras DI, Hyer JM, Paredes AZ, et al. Tumor burden dictates prognosis among patients undergoing resection of intrahepatic cholangiocarcinoma: A tool to guide post-resection adjuvant chemotherapy? Ann Surg Oncol. 2021;28:1970\u20138.","journal-title":"Ann Surg Oncol."},{"key":"16455_CR17","doi-asserted-by":"publisher","first-page":"e1187","DOI":"10.1097\/SLA.0000000000003788","volume":"274","author":"X-F Zhang","year":"2021","unstructured":"Zhang X-F, Xue F, Dong D-H, et al. Number and station of lymph node metastasis after curative-intent resection of intrahepatic cholangiocarcinoma impact prognosis. Ann Surg. 2021;274:e1187\u201395.","journal-title":"Ann Surg."},{"key":"16455_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/SLA.0000000000002064","volume":"267","author":"K Sasaki","year":"2018","unstructured":"Sasaki K, Morioka D, Conci S, et al. The tumor burden score: a new \u201cmetro-ticket\u201d prognostic tool for colorectal liver metastases based on tumor size and number of tumors. Ann Surg. 2018;267:132\u201341.","journal-title":"Ann Surg."},{"key":"16455_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67:93\u20139.","journal-title":"CA Cancer J Clin."},{"key":"16455_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/jso.25486","volume":"120","author":"DI Tsilimigras","year":"2019","unstructured":"Tsilimigras DI, Hyer JM, Moris D, et al. Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis of 706 patients. J Surg Oncol. 2019;120:206\u201313.","journal-title":"J Surg Oncol."},{"key":"16455_CR21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s11605-023-05578-z","volume":"27","author":"MM Munir","year":"2023","unstructured":"Munir MM, Endo Y, Lima HA, et al. Albumin-bilirubin grade and tumor burden score predict outcomes among patients with intrahepatic cholangiocarcinoma after hepatic resection: a multi-institutional analysis. J Gastrointest Surg. 2023;27:544\u201354.","journal-title":"J Gastrointest Surg."},{"key":"16455_CR22","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/bjs.11464","volume":"107","author":"DI Tsilimigras","year":"2020","unstructured":"Tsilimigras DI, Moris D, Hyer JM, et al. Hepatocellular carcinoma tumour burden score to stratify prognosis after resection. Br J Surg. 2020;107:854\u201364.","journal-title":"Br J Surg."},{"key":"16455_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.829407","volume":"12","author":"H Li","year":"2022","unstructured":"Li H, Liu R, Qiu H, et al. Tumor burden score stratifies prognosis of patients with intrahepatic cholangiocarcinoma after hepatic resection: a retrospective, multi-institutional study. Front Oncol. 2022;12:829407.","journal-title":"Front Oncol."},{"key":"16455_CR24","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/XCS.0000000000000557","volume":"236","author":"Z Moazzam","year":"2023","unstructured":"Moazzam Z, Alaimo L, Endo Y, et al. Combined tumor burden score and carbohydrate antigen 19\u20139 grading system to predict outcomes among patients with intrahepatic cholangiocarcinoma. J Am Coll Surg. 2023;236:804\u201313.","journal-title":"J Am Coll Surg."},{"key":"16455_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.20517\/2394-5079.2023.45","volume":"9","author":"M Akabane","year":"2023","unstructured":"Akabane M, Imaoka Y, Sasaki K. The future direction of liver transplantation for intrahepatic cholangiocarcinoma. Hepatoma Res. 2023;9:29.","journal-title":"Hepatoma Res."},{"key":"16455_CR26","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1007\/s00268-021-06265-3","volume":"45","author":"AN Elfadaly","year":"2021","unstructured":"Elfadaly AN, Tsilimigras DI, Hyer JM, et al. Impact of tumor burden score on conditional survival after curative-intent resection for hepatocellular carcinoma: a multi-institutional analysis. World J Surg. 2021;45:3438\u201348.","journal-title":"World J Surg."},{"key":"16455_CR27","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.surg.2019.06.005","volume":"166","author":"F Bagante","year":"2019","unstructured":"Bagante F, Spolverato G, Merath K, et al. Intrahepatic cholangiocarcinoma tumor burden: a classification and regression tree model to define prognostic groups after resection. Surgery. 2019;166:983\u201390.","journal-title":"Surgery."},{"key":"16455_CR28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.surg.2012.12.005","volume":"153","author":"O Hyder","year":"2013","unstructured":"Hyder O, Hatzaras I, Sotiropoulos GC, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery. 2013;153:811\u20138.","journal-title":"Surgery."},{"key":"16455_CR29","doi-asserted-by":"crossref","unstructured":"Park Y-K, Kim B-W, Wang H-J, Kim M-W. Hepatic resection for hepatocellular carcinoma meeting Milan criteria in Child-Turcotte-Pugh class a patients with cirrhosis. In: Paper presented at transplantation proceedings 2009.","DOI":"10.1016\/j.transproceed.2008.07.146"},{"key":"16455_CR30","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1007\/s00268-010-0655-5","volume":"34","author":"P Gassmann","year":"2010","unstructured":"Gassmann P, Spieker T, Haier J, Schmidt F, Mardin WA, Senninger N. Prognostic impact of underlying liver fibrosis and cirrhosis after curative resection of hepatocellular carcinoma. World J Surg. 2010;34:2442\u201351.","journal-title":"World J Surg."},{"key":"16455_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.asjsur.2018.01.001","volume":"41","author":"SK Kamarajah","year":"2018","unstructured":"Kamarajah SK. Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): a surveillance, end results, and epidemiology (SEER) database analysis. Asian J Surg. 2018;41:551\u201361.","journal-title":"Asian J Surg."},{"key":"16455_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/bjc.2016.155","volume":"115","author":"T Kondo","year":"2016","unstructured":"Kondo T, Okabayashi K, Hasegawa H, Tsuruta M, Shigeta K, Kitagawa Y. The impact of hepatic fibrosis on the incidence of liver metastasis from colorectal cancer. Br J Cancer. 2016;115:34\u20139.","journal-title":"Br J Cancer."},{"key":"16455_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/jhbp.155","volume":"22","author":"JB Andersen","year":"2015","unstructured":"Andersen JB. Molecular pathogenesis of intrahepatic cholangiocarcinoma. J Hepatobil Pancreat Sci. 2015;22:101\u201313.","journal-title":"J Hepatobil Pancreat Sci."},{"key":"16455_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.trsl.2019.02.006","volume":"209","author":"C Chandler","year":"2019","unstructured":"Chandler C, Liu T, Buckanovich R, Coffman LG. The double-edge sword of fibrosis in cancer. Transl Res. 2019;209:55\u201367.","journal-title":"Transl Res."},{"key":"16455_CR35","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.hpb.2019.11.009","volume":"22","author":"DH Dong","year":"2020","unstructured":"Dong DH, Zhang XF, Lopez-Aguiar AG, et al. Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection. HPB Oxford. 2020;22:1149\u201357.","journal-title":"HPB Oxford."},{"key":"16455_CR36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/jso.24678","volume":"116","author":"K Sasaki","year":"2017","unstructured":"Sasaki K, Margonis GA, Andreatos N, et al. The prognostic utility of the \u201ctumor burden score\u201d based on preoperative radiographic features of colorectal liver metastases. J Surg Oncol. 2017;116:515\u201323.","journal-title":"J Surg Oncol."},{"key":"16455_CR37","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1001\/archsurg.136.5.528","volume":"136","author":"MM Bilimoria","year":"2001","unstructured":"Bilimoria MM, Lauwers GY, Doherty DA, et al. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg. 2001;136:528\u201335.","journal-title":"Arch Surg."},{"key":"16455_CR38","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7:1104\u201312.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"16455_CR39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/hep4.1841","volume":"6","author":"J Vieira Barbosa","year":"2022","unstructured":"Vieira Barbosa J, Milligan S, Frick A, et al. Fibrosis-4 index as an independent predictor of mortality and liver-related outcomes in NAFLD. Hepatol Commun. 2022;6:765\u201379.","journal-title":"Hepatol Commun."},{"key":"16455_CR40","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jhep.2021.12.031","volume":"76","author":"J Boursier","year":"2022","unstructured":"Boursier J, Hagstr\u00f6m H, Ekstedt M, et al. Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events. J Hepatol. 2022;76:1013\u201320.","journal-title":"J Hepatol."},{"key":"16455_CR41","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846\u201354.","journal-title":"Hepatology."},{"key":"16455_CR42","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gut.2007.146019","volume":"57","author":"SA Harrison","year":"2008","unstructured":"Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57:1441\u20137.","journal-title":"Gut."},{"key":"16455_CR43","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"J-H Lee","year":"2010","unstructured":"Lee J-H, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Digestive Liver Dis. 2010;42:503\u20138.","journal-title":"Digestive Liver Dis."},{"key":"16455_CR44","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s10096-011-1513-6","volume":"31","author":"G Usluer","year":"2012","unstructured":"Usluer G, Erben N, Aykin N, et al. Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C. Eur J Clin Microbiol Infect Dis. 2012;31:1873\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"16455_CR45","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/j.1440-1746.2011.06774.x","volume":"26","author":"LA Adams","year":"2011","unstructured":"Adams LA, George J, Bugianesi E, et al. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2011;26:1536\u201343.","journal-title":"J Gastroenterol Hepatol."},{"key":"16455_CR46","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.dld.2011.03.009","volume":"43","author":"R Bruno","year":"2011","unstructured":"Bruno R, Sacchi P, Cima S, et al. Correlation between FIB4, liver stiffness, and metabolic parameters in patients with HIV and hepatitis C virus co-infection. Digestive Liver Dis. 2011;43:575\u20138.","journal-title":"Digestive Liver Dis."},{"key":"16455_CR47","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jceh.2016.08.001","volume":"6","author":"S Taneja","year":"2016","unstructured":"Taneja S, Tohra S, Duseja A, Dhiman RK, Chawla YK. Noninvasive assessment of liver fibrosis by transient elastography and FIB4\/APRI for prediction of treatment response in chronic hepatitis C: an experience from a tertiary care hospital. J Clin Exper Hepatol. 2016;6:282\u201390.","journal-title":"J Clin Exper Hepatol."},{"key":"16455_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0973-6883(12)60103-0","volume":"2","author":"A Arora","year":"2012","unstructured":"Arora A, Sharma P. Non-invasive diagnosis of fibrosis in non-alcoholic fatty liver disease. J Clin Exper Hepatol. 2012;2:145\u201355.","journal-title":"J Clin Exper Hepatol."},{"key":"16455_CR49","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4254\/wjh.v5.i10.584","volume":"5","author":"M Tahiri","year":"2013","unstructured":"Tahiri M, Sodqi M, Lahdami FEZ, et al. Risk factors for liver fibrosis among human immunodeficiency virus monoinfected patients using the FIB4 index in Morocco. World J Hepatol. 2013;5:584.","journal-title":"World J Hepatol."},{"key":"16455_CR50","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cgh.2016.01.009","volume":"14","author":"M Lu","year":"2016","unstructured":"Lu M, Li J, Zhang T, et al. Serum biomarkers indicate long-term reduction in liver fibrosis in patients with sustained virological response to treatment for HCV infection. Clin Gastroenterol Hepatol. 2016;14:1044-55.e1043.","journal-title":"Clin Gastroenterol Hepatol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16455-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16455-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16455-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T18:02:10Z","timestamp":1735927330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16455-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["16455"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16455-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}